American Society of Addiction Medicine
American Society of Addiction Medicine
Lead Story: Daily E-cigarette Use and the Surge in JUUL Sales: 2017–2019
Lead Story: Daily E-cigarette Use and the Surge in JUUL Sales: 2017–2019
Lead Story: Daily E-cigarette Use and the Surge in JUUL Sales: 2017–2019
Tuesday 7th June 2022
Unpack the impact of JUUL sales on youth vaping, varenicline's role in smoking cessation, caregiver support, and innovative intoxication detection.
9 minutes
Informative
Thought-provoking
Empowering
Educational
Supportive
About this podcast
Author:
American Society of Addiction Medicine
Overview:
Categories:
Innovative Treatments & Recovery Paths
Navigating Alcohol Dependency
Family Recovery from Addiction
Nutritional Pathways to Recovery
Navigating Intimate Relationships
Links:
Visit site
Episodes:
166 (View all)
Do you want to link to this podcast?
Get the buttons here!JUUL Sales Spike: Unpacking the Impact on Youth Vaping Habits
The surge in US Juul Sales was associated with a sharp rise in Daily e-cigarette vaping and Daily tobacco use among us youth, not young, adults.
Imagine a sudden spike in the popularity of e-cigarettes among young people. This episode of 'This Week in Addiction Medicine' from ASAM dives into the surge in JUUL sales between 2017 and 2019 and its ripple effects on daily e-cigarette use among US youth. The featured study breaks down how this surge influenced first-time tobacco use and the onset of daily vaping across different age groups.
The findings are eye-opening, revealing a sharp rise in daily e-cigarette use among young Americans. But that's just the tip of the iceberg. The episode also delves into the effectiveness of varenicline, a medication for smoking cessation, by exploring its impact on reducing negative emotions and cravings post-quit. You'll hear about a systematic review focusing on interventions for caregivers of methamphetamine users, highlighting the need for more comprehensive support beyond their caregiving roles.
In an innovative twist, the episode covers a study on a 'virtual breathalyzer' that uses motion sensors from wearable devices to detect intoxication. This method offers a less intrusive alternative to traditional sobriety tests. There's also a segment on the need for better education for future practitioners to handle these emerging therapies effectively. The conversation wraps up with a look at strategies to prevent opioid overdose using naloxone and the rising trend of stimulant and opioid co-use.
An editorial from 'Addiction' underscores the necessity for timely, comprehensive data to combat the opioid crisis effectively. This episode is packed with crucial insights for anyone interested in the evolving landscape of addiction medicine.